RS

Romy Seth

Scientist Reviewer at Cancer Prevention and Research Institute of Texas

New York, New York

Overview 

Romy Seth is a seasoned professional with a diverse background in healthcare merchant banking, private equity, and venture capital. Currently serving as a Founding Partner at Tungsten Advisors, he has also held key roles at prestigious organizations like the Cancer Prevention and Research Institute of Texas and NASA Ames Research Center, showcasing a strong track record in corporate development and investment banking. With extensive experience in financial modeling and due diligence, Romy's career highlights include co-founding iPill Dispenser and serving as Vice President at Ferghana Partners.

Work Experience 

  • Founding Partner

    2019 - Current

    Tungsten Advisors (www.tungstenadv.com) is an investment banking firm focused on strategic advisory and corporate finance for healthcare and technology companies. Tungsten provides transactional services including financings (private placements/PIPEs), corporate licensing and mergers and acquisitions (M&A). Tungsten also focuses on company incubation and makes direct investments alongside the creation of new companies in healthcare and technology.

  • Scientist Reviewer

    2022

    CPRIT is a state agency with a $6 billion fund to invest in innovative cancer research and prevention efforts in Texas. The four areas that CPRIT funds include therapeutics, devices and diagnostics, new and emerging technologies (e.g. AI, bioinformatics, production of radionuclides, manufacture of cell-based therapies).

Cancer Prevention and Research Institute of Texas is a state agency that invests in cancer prevention and academic research.

Raised $2,000,000.00.

  • Co-Founder

    2020

    iPill is a tech enabled device to improve treatment compliance in patients with Opioid Use Disorder.

iPill Dispenser is a digital health medical device.

  • Vice President

    2014 - 2019

    Ferghana Partners (New York and London) is an Investment Banking firm focused on M&A, private placements/PIPES and corporate partnering in the life sciences (therapeutics, diagnostics, and medical devices) sector.

Ferghana Partners is an investment banking group that consults in acquisitions, divestments and financing solutions for various sectors.

  • Analyst

    2012 - 2014

    Prism Capital is a Chicago-based private equity firm with $190 million in assets under management. Prism provides subordinated debt to lower middle market companies through the Prism Mezzanine Fund and expansion capital to smaller growing companies through our equity fund, Prism Opportunity Fund. We partner with superior management teams and private equity professionals to finance growth, recapitalizations and buyouts.

Prism Capital is a private equity firm specializing in growth finance, recapitalizations, and buyouts.

  • Chemical Engineer - Space Biosciences Division

    2011 - 2011

    In the Space Biosciences Division at NASA's Ames Research Center, we perform the biological research and technology development necessary to tackle life science challenges and enable NASA's long-term human exploration mission. In addition to designing and conducting ground and spaceflight experiments, we develop advanced research platforms for the International Space Station to enable the broader scientific community to conduct life science experiments in microgravity.

Articles About Romy

Relevant Websites